Boston biotech startup Gingko Bioworks has announced the raise of $275 million in Series D funding to out its Bioworks3 production facility. The funding from previous investors Viking , Y Combinator’s Continuity Fund, Cascade Investment, , as well as new investor, Atlantic. The company previously raised over $154 million, bringing the total up to… Read More

Related posts: